Industry Insight: New Environment
- Topics:
- Pharmeceuticals
- Tags:
- Accounting,
- Environment,
- Industry,
- Management,
- Pharmaceutical Company,
- PricewaterhouseCoopers Consulting,
- Strategy
- Source:
- PricewaterhouseCoopers
FREE Registration is required
Overview: Protecting intellectual property is paramount in the pharmaceutical industry. The new rules require that companies disclose their reasons for doing a deal and paying a premium over book value. Because this is sensitive data in a consolidating industry, companies and their advisers must develop best practices for complying with these new disclosure requirements. In summary, the new accounting rules will have a major impact on the pharmaceutical industry.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: HTML | Pages: 3



